Renewed information on Erwinase® 10,000 IU/vial (crisantaspase): shortage and instructions for use for further batches 179a* and 180a*
2017.04.12
Active substance: crisantaspase
The company Jazz Pharmaceuticals Germany GmbH is circulating information on the fact that, due to a temporary shortage, Erwinase® 10.000 I.U./vial powder for solution for injection is currently only available under consideration of the provisions of Section 73 (3) AMG. In connection with the import of Erwinase® from The United Kingdom, the company is also issuing information on the fact that a 5 μm filter needle is to be used when administering batches 179a* and 180a*.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN